Objective To examine the use of multiple daily injections (MDI), insulin pumps, self-measured blood glucose (SMBG), and continuous glucose monitoring (CGM) systems, and their association with glycated hemoglobin (HbA1c), diabetic ketoacidosis (DKA), and severe hypoglycemia. Methods In a pediatric population-based nationwide cross-sectional study, we analyzed data from 2623 participants up to 18 years of age with type 1 diabetes, using 2017 annual data from the Norwegian Childhood Diabetes Registry. HbA1c was adjusted for age, gender, and diabetes duration. Using a linear mixed-effects model, we assessed HbA1c and the incidence of DKA and severe hypoglycemia according to the use of MDI, insulin pumps, SMBG, and CGM. Results We obser...
peer reviewedBACKGROUND: studies investigating the effect of real-time continuous glucose monitorin...
BACKGROUND: Recently developed technologies for the treatment of type 1 diabetes mellitus include a ...
Objective: Retrospective continuous glucose monitoring (CGM) can guide insulin pump adjustments, how...
Objective To examine the use of multiple daily injections (MDI), insulin pumps, self-measured blood...
Aims: To assess glycaemic control in ≥15-year-old patients with type 1 diabetes treated in Tampere U...
Introduction. The automatic suspension of the insulin pump and discontinuationof insulin delivery in...
As of 2015, 9.4% of the US population had a diagnosis of Diabetes Mellitus (DM). Although most of th...
BACKGROUND: Insulin pumps and real-time continuous glucose monitoring devices have recently been com...
Aims/hypothesis: While the use of insulin pumps in paediatrics has expanded dramatically, there is...
Aims/hypothesis The aim of this multicentre, randomised, controlled crossover study was to determin...
Background: Insulin pumps and real-time continuous glucose monitoring devices have recently been com...
Background: Insulin pumps and real-time continuous glucose monitoring devices have recently been com...
Objective: This study aimed to compare metabolic control measured as hemoglobin A1c (HbA1c), the ris...
Introduction: Diabetes management in very young children remains challenging. Glycaemic targets are ...
Introduction: In the last 5 years, the use of automatic insulin delivery systems has been increasing...
peer reviewedBACKGROUND: studies investigating the effect of real-time continuous glucose monitorin...
BACKGROUND: Recently developed technologies for the treatment of type 1 diabetes mellitus include a ...
Objective: Retrospective continuous glucose monitoring (CGM) can guide insulin pump adjustments, how...
Objective To examine the use of multiple daily injections (MDI), insulin pumps, self-measured blood...
Aims: To assess glycaemic control in ≥15-year-old patients with type 1 diabetes treated in Tampere U...
Introduction. The automatic suspension of the insulin pump and discontinuationof insulin delivery in...
As of 2015, 9.4% of the US population had a diagnosis of Diabetes Mellitus (DM). Although most of th...
BACKGROUND: Insulin pumps and real-time continuous glucose monitoring devices have recently been com...
Aims/hypothesis: While the use of insulin pumps in paediatrics has expanded dramatically, there is...
Aims/hypothesis The aim of this multicentre, randomised, controlled crossover study was to determin...
Background: Insulin pumps and real-time continuous glucose monitoring devices have recently been com...
Background: Insulin pumps and real-time continuous glucose monitoring devices have recently been com...
Objective: This study aimed to compare metabolic control measured as hemoglobin A1c (HbA1c), the ris...
Introduction: Diabetes management in very young children remains challenging. Glycaemic targets are ...
Introduction: In the last 5 years, the use of automatic insulin delivery systems has been increasing...
peer reviewedBACKGROUND: studies investigating the effect of real-time continuous glucose monitorin...
BACKGROUND: Recently developed technologies for the treatment of type 1 diabetes mellitus include a ...
Objective: Retrospective continuous glucose monitoring (CGM) can guide insulin pump adjustments, how...